Key Highlights

  • Adjusted EPS of USD 2.09 rose 62% from USD 1.29 and topped the consensus estimate of USD 1.87.
  • Net sales of USD 1.868 billion rose 4% and edged above the consensus estimate of USD 1.84 billion.
  • Operating EBITDA of USD 469 million increased 8%, lifting the Margin 80 basis points to 25.1%.
  • Full year adjusted EPS guidance was raised to USD 7.47 to 7.52, with a USD 250 million buyback planned.

DuPont de Nemours, Inc. (NYSE:DD) reported third quarter 2026 adjusted EPS of USD 2.09, up 62% from USD 1.29 a year earlier and above a consensus estimate of USD 1.87. Net sales rose 4% to USD 1.868 billion from USD 1.795 billion, above a consensus estimate of USD 1.84 billion, with Organic Sales up 5% and currency a 1% headwind. On a GAAP basis, income from continuing operations rose 68% to USD 171 million, equal to diluted EPS of USD 1.24 against USD 0.70 a year earlier. The company said the gain in adjusted EPS came from higher segment Earnings and lower net interest expense, tax rate and share count.

Segment Margins and Cash Conversion

Healthcare and Water Technologies net sales rose 4% to USD 865 million, with operating EBITDA of USD 263 million and a margin of 30.4%, up 80 basis points. Healthcare Technologies grew at a mid-single digit organic rate on personal protection and medical packaging, while Water Technologies grew at a low-single digit rate on industrial water, semiconductor and specialty markets, partly offset by disruptions in the Middle East. Diversified Industrials net sales rose 4% to USD 1.003 billion, with operating EBITDA up 11% to USD 242 million and a margin of 24.1%, up 140 basis points, as aerospace and electric vehicle battery applications supported Industrial Technologies. Operating Cash Flow from continuing operations was USD 410 million, and transaction-adjusted free cash flow of USD 341 million represented 121% conversion. Chief Executive Officer Lori Koch said the quarter again exceeded the company guidance, citing mid-single digit organic growth, Operating Leverage and disciplined Capital allocation.

Raised 2026 Guidance and Portfolio Changes

The company projects full year net sales of about USD 7.19 billion, operating EBITDA of about USD 1.785 billion and adjusted EPS of USD 7.47 to 7.52. The chief financial officer said organic growth is now projected at about 4.5%, with each measure at or above the high end of earlier guidance. Fourth quarter guidance calls for net sales of about USD 1.825 billion, operating EBITDA of about USD 455 million and adjusted EPS of USD 1.90 to 1.95. Share counts reflect a 1-for-3 Reverse Stock Split effective June 24, 2026, and results are shown on a continuing operations basis after the Aramids sale completed on April 1, 2026 and the separation of the Electronics Business on November 1, 2025.

Fourth Quarter Guidance Against Third Quarter Actuals and Cash Position

Fourth quarter adjusted EPS guidance of USD 1.90 to 1.95 compares with USD 2.09 in the third quarter, while net sales guidance of about USD 1.825 billion compares with USD 1.868 billion. Operating EBITDA guidance of about USD 455 million compares with USD 469 million. Cash and cash equivalents stood at USD 1.652 billion against USD 715 million at year end 2025, and long-term Debt was USD 3.094 billion against USD 3.134 billion. The company completed a USD 250 million accelerated share purchase and substantially finished USD 100 million of open market repurchases in the quarter, and announced the intent to buy back USD 250 million of shares in the fourth quarter.